Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency
Christopher A. Bates(Purdue University West Lafayette), John M. Routes(University of Colorado Anschutz Medical Campus), David A. Lynch(McMaster University), Kevin K. Brown(Health Protection Surveillance Centre), Carlyne D. Cool(University of Colorado Anschutz Medical Campus), Misoo C. Ellison(University of Colorado Anschutz Medical Campus)
Cited by 348
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2003|762